0000899243-22-005932.txt : 20220211
0000899243-22-005932.hdr.sgml : 20220211
20220211184258
ACCESSION NUMBER: 0000899243-22-005932
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220209
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DiPietro Kenneth
CENTRAL INDEX KEY: 0001540188
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 22623560
MAIL ADDRESS:
STREET 1: C/O BIOGEN IDEC INC.
STREET 2: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 JACOBS STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 222 JACOBS STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-09
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001540188
DiPietro Kenneth
C/O CEREVEL THERAPEUTICS HOLDINGS, INC.
222 JACOBS STREET, SUITE 200
CAMBRIDGE
MA
02141
0
1
0
0
Chief Human Resources Officer
Stock Option (Right to Buy)
30.36
2022-02-09
4
A
0
75985
0.00
A
2032-02-09
Common Stock
75985
75985
D
25% of this option shall vest and become exercisable on February 9, 2023, with the remainder vesting in thirty-six (36) monthly installments thereafter.
/s/ Mark Bodenrader, as Attorney-in-Fact
2022-02-11